Brief: Vectivbio Holding AG Announces Successful Opening Of US IND For Apraglutide For Acute Graft-Versus-Host Disease
20/10/2021 12:18
Oct 20 (Reuters) - VectivBio Holding AG VECT.O :
* VECTIVBIO ANNOUNCES SUCCESSFUL OPENING OF US IND FOR
APRAGLUTIDE
FOR ACUTE GRAFT-VERSUS-HOST DISEASE
* VECTIVBIO HOLDING AG - DOSING OF FIRST PATIENT EXPECTED IN
1Q
2022
* VECTIVBIO HOLDING AG - INTERIM DATA ANTICIPATED IN 2H 2022
Source text for Eikon: ID:nGNX88NgGY
Further company coverage: VECT.O
((reuters.briefs@thomsonreuters.com;))
Recent news on VectivBio Holding AG
See all newsBrief: Ironwood And VectivBio Announce Expiration Of Hart-Scott-Rodino Waiting Period For Proposed Acquisition Of VectivBio
Brief: Ironwood Pharmaceuticals Says If Deal Aborts, VectivBio To Pay Termination Fee
U.S. STOCKS ON THE MOVE-Pfizer, Zoom Video, American Airlines
U.S. STOCKS ON THE MOVE-Atea Pharma, Microbot Medical, Krystal
U.S. STOCKS ON THE MOVE-NuScale Power Corp, Foot Locker, Greenhill